ALA - Arovella Therapeutics

[rcm617]

Dropped back quickly from the 15c at the end of last month but seems to be starting to pick up the last few days. Not much in the quarterly, just building towards a phase 1 trial for non Hodgin's Lymphoma, so likely to be slow progress for the rest of the year.

 

[rcm617]

Another one of my picks that is going backwards on no news. Likely to be slow for a while as little news likely for a while.

 

[rcm617]

Has had a pretty good month after announcing the manufacturing scale up of ALA 101, allowing it to produce sufficient quantities for the phase 1 clinical trials.

 

[bettamania]

Another champion line past financial year. just give a bit 3 more cents tickle and she will challenge her all time high.

 

[bettamania]

Almost got tickled. My MTF trend following system. Another happy day indeed

Again I need to put a disclaimer here not a recommendation to buy and sell

 

[rcm617]

Quarterly out last week outlining program for next year leading to first in human clinical trials and pointing to healthy cash balance after the raising earlier this year. Looks like fairly slow progress as with all biotechs, however a very promising technology.

 

[rcm617]

Not much new in the annual report, still waiting for progress to human trials. Slowly drifting back down. Still had 12 million cash at the end of the financial year which should last them till the trials start.

 

[rcm617]

No new news, up about 10% this month. Maybe a slow rise in price heading towards the human trials.

 

[rcm617]

Pocketed a 3 million dollar research grant which according to the quarterly will give them enough money to get results from the first human trials. Price holding pretty well.

 

[rcm617]

Not much new news but holding it's share price pretty well. Slow progress till the human trials.